Université de Montréal
Mrs. Michelle Savoie is also an Assistant professor, practical training at the Faculty of Pharmacy of the Université de Montréal. She was the Chief Executive Officer of Montréal InVivo. Mrs. Savoie brings to the organization over 20 years of experience in the health field and pharmaceutical sector. She has held strategic positions at various Pharma companies, including Schering Canada, Eli Lilly Canada and Bristol-Myers Squibb. In addition, she currently sits on several boards and committees, including those at Université de Montréal, INESSS as well as the boards of directors of the Quebec Network for Personalized Healthcare (QNPHC) and the Personalized Medicine Partnership for Cancer (PMPC). Mrs. Savoie was actively involved in the creation of the Quebec Consortium for Drug Discovery, the Quebec Personalized Health Care Strategy and Néomed.
A biochemist by training, Mrs. Savoie also holds an MBA from the University of Ottawa, a Masters in Public Health (MPH) from Boston University, a PhD in biomedical sciences from Université de Montréal as well as a Masters in Law and Health policy (LL.M.) from the Université de Sherbrooke.